7+3(İDARUBİSİN) PROTOKOLÜ

Kaynaklar:

1-1998 AML Collaborative Group 1998 "A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. " Br.J Haematol. 103(1):100-109.

2-Pautas, C., F. Merabet, X. Thomas, et al. 2010. "Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study." J Clin Oncol 28(5):808-814.

3-Vogler, W. R., E. Velez-Garcia, R. S. Weiner, et al. 1992. "A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study." J.Clin Oncol. 10(7):1103-1111.

4-Berman, E., G. Heller, J. Santorsa, et al. 1991. "Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia." Blood 77(8):1666-1674.